Morphological Reversion of srcts-NRK Cells Rat kidney cells infected with ts25, a T-class mutant of Rous sarcoma virus Prague strain (,srcts-NRK)3) were cultured at permissive temperature (32°C) or at nonpermissive temperature (39°C) in Eagle's minimal essential medium (MEM) supplemented with 10% fetal bovine serum (FBS, Gibco Laboratories, Grand Island, NY., U.S.A.). The cells maintained at 32°C were seeded into a 96-well microtiter plate (2 x 104cells/200/il/well) and cultured for 4 hours at 32°C in a CO2 incubator. Solutions of various concentrations of reveromycins (10 fA each) were added and morphological reversion of 5rcts-NRK cells was observed under a microscope after 18 to 20 hours incubation at 32°C. The activity was presented as ft Present address:
Reveromycins A, B, C and D were found as inhibitors of mitogenic activity induced by epidermal growth factor (EGF) in Balb/MK cells. In our knowledge, natural products which are structurally related to reveromycins are not reported. Weare interested in the biological activities of reveromycins because of their unique chemical structures. Biological activities of reveromycin Aon animal cells and fungi were preliminarily reported1}. In this paper, we report in detail the effects of reveromycin Aon eukaryotic cell growth compared with those of reveromycins B, C and D.
Materials and Methods
Inhibition of Mitogen Response Induced by EGF Quiescent Balb/MK cells for antimitogenic assays were prepared as previously described2). Mitogenic activity can be measured by the incorporation of [3H]thymidine (ICN Radiochemicals, Irvine, CA, U.S.A.) into quiescent Balb/MKcells 17 hours after addition of EGF(5ng/ml, receptor grade, Collaborative Research Inc., Bed ford, MA., U.S.A.). Radioactivity of trichloroacetic acid precipitable materials in the presence or absence of reveromycinswas quantified.
Morphological Reversion of srcts-NRK Cells Rat kidney cells infected with ts25, a T-class mutant of Rous sarcoma virus Prague strain (,srcts-NRK)3) were cultured at permissive temperature (32°C) or at nonpermissive temperature (39°C) in Eagle's minimal essential medium (MEM) supplemented with 10% fetal bovine serum (FBS, Gibco Laboratories, Grand Island, NY., U.S.A.). The cells maintained at 32°C were seeded into a 96-well microtiter plate (2 x 104cells/200/il/well) and cultured for 4 hours at 32°C in a CO2 incubator. Solutions of various concentrations of reveromycins (10 fA each) were added and morphological reversion of 5rcts-NRK cells was observed under a microscope after 18 to 20 hours incubation at 32°C. The activity was presented as Antifungal Activity
For evaluation of antifungal activity ofreveromycins, synthetic amino-acid medium fungal (SAAMF)6) was employed as medium. The pH of the medium was adjusted with 1n HC1between 3.0 and 7.4. Candida albicans IFO 1 594 was used as test organism. Fluconazole which is a synthetic triazole antifungal agent was purified from Diflucan capsules (Pfizer) and used for comparison. MICs were determined by broth dilution method using a 96-well microtiter plate. Yeast inocula were prepared in mediumto final inocula size of 104/ml by hemacytometer counting. Various concentrations of drugs diluted in DMSO were added to the medium. The final concentration of the solvent (DMSO) was 4%(v/v). The plates were incubated at 37°C for 48 hours. The MICs were defined as the lowest concentrations of the drugs at which the growth of yeasts was inhibited.
The pKa value of reveromycin A was measured with a Toa AUT-1automatic titrator in 20%MeOH solution.
Preparation of Trimethyl Ester of Reveromycin A Reveromycin A (10 mg) was dissolved in MeOH(1 ml) and excess diazomethane -ether solution for 4 hours at room temperature to give quantitative trimethyl ester.
Effect of Reveromycin A on Macromolecular Synthesis srcts-NRK cells (1.5 x 105 cells/ml) were seeded onto a 48-multiwell plate in MEMsupplemented with 10% FBS and cultured at 32°C for 17 hours. The culture medium was changed to 2% FBS containing MEMand [3H]thymidine,
[3H]uridine, or [14C]phenylalanine (2 /iCi/ml, ICN Radiochemicals) was add to the cells. The serial dilution of reveromycin A was added simultaneously. After 5-hour labeling, the cells were harvested and the acid-insoluble fractions were collected. The radioactivity was counted by a liquid scintillation counter. Reveromycin A did not inhibit EGF-receptor kinase (IC50 > 50 fig/ml). Therefore, it was considered that the inhibitory mechanismof reveromycins against the signal transduction of EGFis different from that of EGF-receptor kinase inhibitors such as erbstatin8) or lavendustin A9).
Morphological Reversion of 5rcts-NRK Cells Whensrcts-NRK cells were cultured at 32°C, spherical transformed cells were observed. Onthe other hand, when they were cultured at 39°C, flat normal cells appeared taking the place of spherical cells. Reveromycins induced morphological reversion of srcts-NRK cells from spherical transformed cells to flat normal cells at 32°C (Fig. 2) , except for reveromycin B which showed little morphological reversion even at the concentration of 50jug/ml. Reveromycins A, C and D exhibited EC5Osof about 1.58^g/ml and the activity was observed up to the concentration of 50 /xg/ml without cytotoxicity (Table 1) . Flow cytometric analysis revealed that reveromycin A inhibited the cell cycle progression ofisrcts-NRK cells at G1 phase (data not shown). It was reported that p60v'src which possesses tyrosine kinase activity is involved in the Gi/S transition in the cell cycle10'1 1}. It was possible that both growth factors and p60v"src kinase act MIC (jug/ml) with an initial pH of: Several microbial products which induce morphological change of oncogene-expressed cells are known. A benzoquinoid antibiotic, herbimycin A was rediscovered as a compound which induces morphological reversion of srcts-NRK cells (EC100 =0.5 /ig/ml)12). In addition, oxanosine13) as a guanosine analogue, azatyrosine 14) as a tyrosine analogue, acetoxycycloheximide, cycloheximide1 5), epiderstatin1 6) as glutarimide antibiotics, 2-demethylsteffimycin D17) as an anthracycline antibiotic, and trapoxins A and B18) as cyclotetrapeptides have already been reported. The chemical structures of reveromycins distinctly differ from these compounds.
Antiproliferative
Activity against Human Tumor Cell Lines, KB and K562 Reveromycins A, C and D exhibited antiproliferative activity against KB and K562 cells in vitro, but reveromycin B did not, even at the concentration of 50/ig/ml. Reveromycins A, C and D were more effective than 5-fluorouracil on these cell lines ( Table 2 ). The in vivo antitumor activity of reveromycin A will be described elsewhere. Antifungal Activity Reveromycin A showed antifungal activity but did not show antibacterial activity1}. Antifungal activities of reveromycins were examined against Candida albicans IFO 1594 at various initial pH of the medium (Table 3) . At the physiological pH (7.4), reveromycins had no potency (MIC: >500^g/ml) in SAAMF. In the case of fluconazole, reducing the pH in SAAMF from 7.4 to 3.0 resulted in a lower of the anticandidal activity. In contrast, anticandidal activity of reveromycins were markedly enhanced when the initial pH of the medium was decreased from 7.4 to 3.0. The drastic change of anticandidal activity was observed in the pH 5 to 3 region. This result was compatible with the data ofpKa. value (4.2) of reveromycin A. However,trimethyl ester derivative of reveromycin A, which was prepared by diazomethane treatment, was not active even at pH 3. These results suggest that the nondissociative form of reveromycin's carboxylic acid are necessary for the anticandidal activity. The MICvalue at pH 3 for reveromycins A, C and D was 2.0/*g/ml, but that for reveromycin B was approximately 8-fold higher.
Effect of Reveromycin A on Macromolecular Synthesis
and In Vitro Protein Synthesis Reveromycin A inhibited protein synthesis stronger than DNAor RNAsynthesis as shown in Fig. 3 . The IC50 for protein synthesis of srcts-NRK cell was about 1 um. Differencial effect of reveromycin A on in vitro protein synthesis of rabbit reticulocyte and E. coli was worth noting. No inhibition of in vitro protein synthesis of E. coli by reveromycin Awas found at lO fiu. In contrast, reveromycin A inhibited that of rabbit reticulocyte at the extremely low concentration (IC5O=40nM) (Fig. 4) . This observation shows that inhibition of protein synthesis by reveromycin A is selective to eukaryotic cells which was also implied based on the antimicrobial spectrum; reveromycin A inhibited fungal growth but not the bacterial growth. Inhibition of protein synthesis in vitro was caused at the lower concentration compared with that in intact srcts-NRK cells. This is thought to be due to the low membranepermeability of reveromycin A. The relationship between action on mitogen responses caused by EGFor p60v~src and inhibition of protein synthesis in eukaryotic cells by reveromycin A is now under investigation.
